The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -27.40%. However, over the past six months, we’ve seen a weaker performance of 3.54%. The price of NVAX fallen by 21.66% over the last 30 days. And in the last five days, it has surged by 26.00%.
Currently, the stock price of Novavax, Inc (NVAX) is $8.48. In the most recent trading session, the stock underwent a significant upswing, peaking at $25.0 after opening at $8.48. The stock touched a low of $6.0 before closing at $8.03.
The stock market performance of Novavax, Inc has been very steady. Over the last year, the company’s stock hit its highest at $15.22 on 10/02/24, while the lowest price during the same time frame was $5.01, recorded on 04/10/25.
52-week price history of NVAX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Novavax, Inc’s current trading price is -44.28% away from its 52-week high, while its distance from the 52-week low is 69.26%. The stock’s price range for this period has been between $5.01 and $15.22. The Healthcare sector company’s shares saw a trading volume of about 6.08 million for the day, which was lower than the average daily volume of 7.94 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Novavax, Inc (NVAX) has experienced a quarterly rise of 33.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.38B and boasts a workforce of 952 employees.
Expert Opinions: Analysts’ Ratings for Novavax, Inc
As of right now, 3 analysts are rating Novavax, Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.85, with a change in price of +0.57. Similarly, Novavax, Inc recorded 7,731,600 in trading volume during the last 100 days, posting a change of +7.21%.
NVAX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for NVAX stands at 6.07. Similarly, the long-term debt-to-equity ratio is also 5.93.
NVAX Stock Stochastic Average
As of today, the raw stochastic average of Novavax, Inc over the past 50 days is 78.39%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 76.60%. Additionally, the Stochastic %K and %D values for the company were 69.85% and 73.94%, respectively, over the past 20 days.
